Javascript must be enabled to continue!
HuR-induced CDK2 translational enhancement aggravates oral tongue squamous carcinoma
View through CrossRef
Abstract
Background
: Oral tongue squamous carcinoma(OTSC) is an extremely malignant tumor specifically characterized by CDK2-mediated cell cycle perturbation.However,the underlying mechanism is poorly understood. HuR,an ubiquitously expressed member of the embryonic lethal abnormal vision family, participated in various malignent cancer. Therefore, this study aimed to explore the relationship of HuR and CDK2 in OTSC.
Materials and methods
: SCC25 cell line was sellected in vitro assay for the impact of HuR knockdown on tumor proliferation or CDK2 expression. IHC or mRNA levels of HuR and CDK2 expression were evaluated in malignent or benign lession tissue. Student’s t-test is used for two-group comparisons, and the one-way ANOVA for multiple group comparisons.
Results
:HuR knockdown reduced SCC25 proliferation, led to cell cycle arrest and dampened the colony formation. Mechanismly, HuR promoted CDK2 translation through binding to 3’untranslated regions. The luciferase activity assay futher authenticated the ARE-mediated HuR regulation on CDK2. Moreover, IHC results indicated that HuR expression exhibited progessive increase in the cases of pathological grade, accompanied by more cytoplasm distribution.Clinal datas demonstrated that the higher expression of HuR and CDK2 indicated poor prognosis and both had positive correlation.
Conclutions
: our study provides a compelling role of HuR in controlling the progression of OTSC by regulating CDK2 dependent cell cycle. These findings may provide a new therapeutic target for OTSC.
Title: HuR-induced CDK2 translational enhancement aggravates oral tongue squamous carcinoma
Description:
Abstract
Background
: Oral tongue squamous carcinoma(OTSC) is an extremely malignant tumor specifically characterized by CDK2-mediated cell cycle perturbation.
However,the underlying mechanism is poorly understood.
HuR,an ubiquitously expressed member of the embryonic lethal abnormal vision family, participated in various malignent cancer.
Therefore, this study aimed to explore the relationship of HuR and CDK2 in OTSC.
Materials and methods
: SCC25 cell line was sellected in vitro assay for the impact of HuR knockdown on tumor proliferation or CDK2 expression.
IHC or mRNA levels of HuR and CDK2 expression were evaluated in malignent or benign lession tissue.
Student’s t-test is used for two-group comparisons, and the one-way ANOVA for multiple group comparisons.
Results
:HuR knockdown reduced SCC25 proliferation, led to cell cycle arrest and dampened the colony formation.
Mechanismly, HuR promoted CDK2 translation through binding to 3’untranslated regions.
The luciferase activity assay futher authenticated the ARE-mediated HuR regulation on CDK2.
Moreover, IHC results indicated that HuR expression exhibited progessive increase in the cases of pathological grade, accompanied by more cytoplasm distribution.
Clinal datas demonstrated that the higher expression of HuR and CDK2 indicated poor prognosis and both had positive correlation.
Conclutions
: our study provides a compelling role of HuR in controlling the progression of OTSC by regulating CDK2 dependent cell cycle.
These findings may provide a new therapeutic target for OTSC.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
HuR-induced CDK2 translational enhancement aggravates oral tongue squamous carcinoma
HuR-induced CDK2 translational enhancement aggravates oral tongue squamous carcinoma
Abstract
Background
: Oral tongue squamous carcinoma(OTSC) is an extremely malignant tumor specifically characterized by CDK2-m...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Cyclin-Dependent Kinase 2 in Cellular Senescence and Cancer. A Structural and Functional Review
Cyclin-Dependent Kinase 2 in Cellular Senescence and Cancer. A Structural and Functional Review
<P>Background: Cyclin-dependent kinase 2 (CDK2) has been studied due to its role in the
cell-cycle progression. The elucidation of the CDK2 structure paved the way to investi...
Expressions of HuR, Methyl-HuR and Phospho-HuR in Endometrial Endometrioid Adenocarcinoma Are Associated with Clinical Features
Expressions of HuR, Methyl-HuR and Phospho-HuR in Endometrial Endometrioid Adenocarcinoma Are Associated with Clinical Features
HuR regulates cytoplasmic mRNA stability and translatability, with its expression correlating with adverse outcomes in various cancers. This study aimed to assess the prognostic va...
Abstract 1610: Inhibiting HuR, a RNA-binding protein, for inhibition of pancreatic cancer EMT and CSCs
Abstract 1610: Inhibiting HuR, a RNA-binding protein, for inhibition of pancreatic cancer EMT and CSCs
Abstract
Purpose
Epithelial- mesenchymal transition (EMT) contributes importantly to cancer cell metastasis, and formation of cancer stem cells (CSCs)...
CMLD-2 Attenuates Myofibroblast Activation and Bleomycin-Induced Pulmonary Fibrosis in Mice through Antagonizing ELAVL1-Mediated Osteopontin mRNA Stabilization
CMLD-2 Attenuates Myofibroblast Activation and Bleomycin-Induced Pulmonary Fibrosis in Mice through Antagonizing ELAVL1-Mediated Osteopontin mRNA Stabilization
Abstract
Background
Fibroblast-myofibroblasts transition (FMT) is one of the hallmark cellular processes in pulmonary fibrosis....
Transcriptional Regulation of Cell Cycle Progression in T‐Cell Leukemia
Transcriptional Regulation of Cell Cycle Progression in T‐Cell Leukemia
The
IKZF1
gene encodes the Ikaros protein that acts as a tumor suppressor in acute lymphoblastic leukemia (ALL). The role of Ikaros in T‐cel...

